Title(s): GOG 0229K. A Phase II Evaluation of BIBF 1120 (IND#) in the Treatment of Recurrent or Persistent Endometrial Carcinoma.
Investigator(s): Esther Rehmus, MD
Contact Information: McDowell Cancer Research at 330-344-6348
Akron General Medical Center • 400 Wabash Avenue • Akron, OH 44307 • 330-344-6000 • 1-800-221-4601 © 2013 Akron General Health System
This site complies with the HONcode standard for trustworthy health information: verify here.
